230 related articles for article (PubMed ID: 25208230)
1. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH.
Khorana AA; Otten HM; Zwicker JI; Connolly GC; Bancel DF; Pabinger I;
J Thromb Haemost; 2014 Nov; 12(11):1928-31. PubMed ID: 25208230
[No Abstract] [Full Text] [Related]
2. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH: reply.
Khorana AA; Zwicker JI; Connolly GC; Pabinger I
J Thromb Haemost; 2015 Feb; 13(2):325-6. PubMed ID: 25408162
[No Abstract] [Full Text] [Related]
3. Prevention of venous thromboembolism in cancer outpatients: guidance from the SSC of the ISTH: comment.
Oo TH
J Thromb Haemost; 2015 Feb; 13(2):323-4. PubMed ID: 25308159
[No Abstract] [Full Text] [Related]
4. The identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH.
Tullius BP; Athale U; van Ommen CH; Chan AKC; Palumbo JS; Balagtas JMS;
J Thromb Haemost; 2018 Jan; 16(1):175-180. PubMed ID: 29178421
[No Abstract] [Full Text] [Related]
5. Vascular Disease Patient Information Page: Cancer-associated thrombosis.
Evans NS; Khorana AA
Vasc Med; 2020 Jun; 25(3):286-288. PubMed ID: 32384252
[No Abstract] [Full Text] [Related]
6. The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.
Wang TF; Zwicker JI; Ay C; Pabinger I; Falanga A; Antic D; Noble S; Khorana AA; Carrier M; Meyer G
J Thromb Haemost; 2019 Oct; 17(10):1772-1778. PubMed ID: 31353841
[No Abstract] [Full Text] [Related]
7. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.
Lyman GH; Bohlke K; Falanga A;
J Oncol Pract; 2015 May; 11(3):e442-4. PubMed ID: 25873061
[No Abstract] [Full Text] [Related]
8. [Thromboembolism--risk, prevention and therapy. Practice Guideline].
;
Orv Hetil; 2009 Dec; 150(52):2335-404. PubMed ID: 20031519
[No Abstract] [Full Text] [Related]
9. Rethinking the approach to thrombosis in patients with cancer.
Khorana AA
Vasc Med; 2020 Jun; 25(3):208-209. PubMed ID: 31718489
[No Abstract] [Full Text] [Related]
10. A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.
Verso M; Agnelli G; Barni S; Gasparini G; LaBianca R
Intern Emerg Med; 2012 Jun; 7(3):291-2. PubMed ID: 22547369
[No Abstract] [Full Text] [Related]
11. Cancer related venous thromboembolism - prophylaxis and therapy.
Gary T
Vasa; 2014 Jul; 43(4):245-51. PubMed ID: 25007902
[TBL] [Abstract][Full Text] [Related]
12. Treatment of venous thrombosis.
Lee AY
Cancer Treat Res; 2009; 148():243-57. PubMed ID: 19377928
[No Abstract] [Full Text] [Related]
13. Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer.
Prisco D; Tufano A; Cenci C; Pignatelli P; Santilli F; Di Minno G; Perticone F
Intern Emerg Med; 2019 Jan; 14(1):21-38. PubMed ID: 30276659
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight heparin or semuloparin should not be recommended for thromboprophylaxis in ambulatory solid cancer patients undergoing chemotherapy.
Oo TH
Thromb Res; 2012 Nov; 130(5):821-2. PubMed ID: 22921591
[No Abstract] [Full Text] [Related]
15. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
[TBL] [Abstract][Full Text] [Related]
16. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
Ades S; Douce D; Holmes CE; Cory S; Prior S; Butenas S; Callas P; Cushman M
J Thromb Haemost; 2018 Jun; 16(6):1099-1106. PubMed ID: 29575637
[TBL] [Abstract][Full Text] [Related]
17. Occult cancer screening in patients with venous thromboembolism: guidance from the SSC of the ISTH.
Delluc A; Antic D; Lecumberri R; Ay C; Meyer G; Carrier M
J Thromb Haemost; 2017 Oct; 15(10):2076-2079. PubMed ID: 28851126
[No Abstract] [Full Text] [Related]
18. Physicians' compliance with the Padua Prediction Score for preventing venous thromboembolism among hospitalized medical patients.
Rossetto V; Barbar S; Vedovetto V; Milan M; Prandoni P
J Thromb Haemost; 2013 Jul; 11(7):1428-30. PubMed ID: 23601653
[No Abstract] [Full Text] [Related]
19. Anticoagulation risk assessment for patients with non-valvular atrial fibrillation and venous thromboembolism: A clinical review.
Pallazola VA; Kapoor RK; Kapoor K; McEvoy JW; Blumenthal RS; Gluckman TJ
Vasc Med; 2019 Apr; 24(2):141-152. PubMed ID: 30755150
[TBL] [Abstract][Full Text] [Related]
20. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
Squizzato A; Ageno W
Thromb Haemost; 2009 Jan; 101(1):31-5. PubMed ID: 19132186
[No Abstract] [Full Text] [Related]
[Next] [New Search]
